Clinical Study
The Neural Correlates of Mental Rotation Abilities in Cannabis-Abusing Patients with Schizophrenia: An fMRI Study
Table 1
Sociodemographic and clinical data.
| | | Control group () | SCZ group () | DD group () |
| | Age (years) | 30.3 (7.9) | 32.6 (8.4) | 30.9 (11.5) | | Lefthanded | 4 | 4 | 1 | | Education level (years) | 18.0 (2.9)** | 11.1 (2.9) | 10.0 (1.9) | | Parental SES | 2.4 (1.1)** | 2.9 (0.7)* | 3.8 (1.2) | | Clinical | | | | | Age of onset (years) | — | 20.8 (4.6) | 20.3 (4.4) | | Duration of illness (years) | — | 11.9 (9.0) | 10.6 (12.2) | | Total medication (mg/day) | — | 568 (276) | 553 (392) | | PANSS positive | — | 17.1 (4.7) | 16.4 (6.0) | | PANSS negative | — | 19.9 (6.2) | 18.9 (5.3) | | PANSS general | — | 37.3 (5.2) | 32.5 (8.7) | | Calgary Depression Scale | — | 3.7 (2.1) | 3.8 (4.1) | | Antipsychotics | — | risperidone (6),
quetiapine (3),
olanzapine (6),
clozapine (5) | risperidone (7),
quetiapine (4),
olanzapine (3),
clozapine (1),
typical (2) |
|
|
DD: dualdiagnosis; SCZ: schizophrenia; SES: socioeconomic status; total medication is in chlorpromazine equivalents; (SD in parentheses); ; .
|
